Literature DB >> 19618662

HbA1c and serum levels of advanced glycation and oxidation protein products in poorly and well controlled children and adolescents with type 1 diabetes mellitus.

Jana Kostolanská1, Vladimír Jakus, L'ubomír Barák.   

Abstract

Diabetes mellitus is associated with hyperglycemia and with accelerated non-enzymatic glycation, increased oxidative stress and free radical production. The aim of the present study was to evaluate the levels of proteins glycation and oxidation parameters, compare them between poorly and well controlled children with type 1 diabetes mellitus, and determine the impact of glycemic control on these parameters. Blood and serum were obtained from 81 patients with type 1 diabetes mellitus (DM1) (20 patients had long-term good glycemic control [GGC], 61 patients had long-term poor glycemic control [PGC]). Thirty-one healthy children were used as controls. Fructosamine (FAM) was determined by a spectrophotometric method, HbA1c was measured by LPLC, serum advanced glycation end-products (s-AGEs) were determined fluorimetrically, and advanced oxidation protein products (AOPP) were measured spectrophotometrically. We observed significantly higher FAM, HbA1c, s-AGEs and AOPP levels in the patients with DM1 compared with controls, and significantly higher FAM, HbA1c and sAGEs levels in the PGC group compared with the GGC group. AOPP was higher in the PGC group than in the GGC group, but not significantly. In the PGC group we observed significant correlations between HbA1c and HDL-C (r = -0.306, p = 0.01), HbA1c and s-AGEs (r = 0.486, p < 0.001), and HbA1c and AOPP (r = 0.447, p < 0.01). s-AGEs significantly correlated with triacylglycerols (TAG) (r = 0.537, p < 0.001) and AOPP with HDL-C (r = -0.336, p < 0.05), TAG (r = 0.739, p < 0.001) and s-AGEs (r = 0.577, p < 0.001). In conclusion, our results showed both glycative and oxidative stress are increased in the PGC diabetic group compared with controls, they are linked with glycemic control, and probably contribute to the development of diabetic complications. We suggest that the measurement of not only HbA1c but also s-AGEs and AOPP may be useful to predict the risk of development of diabetic complications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19618662     DOI: 10.1515/jpem.2009.22.5.433

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  14 in total

1.  Explaining the increased mortality in type 1 diabetes.

Authors:  Chiara Mameli; Sara Mazzantini; Moufida Ben Nasr; Paolo Fiorina; Andrea E Scaramuzza; Gian Vincenzo Zuccotti
Journal:  World J Diabetes       Date:  2015-07-10

Review 2.  Metabolomics in human type 2 diabetes research.

Authors:  Jingyi Lu; Guoxiang Xie; Weiping Jia; Wei Jia
Journal:  Front Med       Date:  2013-02-02       Impact factor: 4.592

3.  Diabetes and increased lipid peroxidation are associated with systemic inflammation even in well-controlled patients.

Authors:  Alliny de Souza Bastos; Dana T Graves; Ana Paula de Melo Loureiro; Carlos Rossa Júnior; Sâmia Cruz Tfaile Corbi; Fausto Frizzera; Raquel Mantuaneli Scarel-Caminaga; Niels Olsen Câmara; Oelisoa M Andriankaja; Meire I Hiyane; Silvana Regina Perez Orrico
Journal:  J Diabetes Complications       Date:  2016-07-21       Impact factor: 2.852

4.  Natural history of age-related retinal lesions that precede AMD in mice fed high or low glycemic index diets.

Authors:  Karen A Weikel; Paul Fitzgerald; Fu Shang; M Andrea Caceres; Qingning Bian; James T Handa; Alan W Stitt; Allen Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-02       Impact factor: 4.799

5.  Variants of the adenosine A(2A) receptor gene are protective against proliferative diabetic retinopathy in patients with type 1 diabetes.

Authors:  Bashira A Charles; Yvette P Conley; Guanjie Chen; Rachel G Miller; Janice S Dorman; Michael B Gorin; Robert E Ferrell; Susan M Sereika; Charles N Rotimi; Trevor J Orchard
Journal:  Ophthalmic Res       Date:  2010-11-19       Impact factor: 2.892

6.  m-Coumaric acid attenuates non-catalytic protein glycosylation in the retinas of diabetic rats.

Authors:  Said Salama Moselhy; Syed Shoeb Razvi; Fawzia A ALshibili; Abudukadeer Kuerban; Mohammed Nihal Hasan; Khadijah Saeed Balamash; Etimad A Huwait; Wesam H Abdulaal; Maryam A Al-Ghamdi; Taha A Kumosani; Khalid Omar Abulnaja; Abdulrahman L Al-Malki; Tadao Asami; Iman M Ismail
Journal:  J Pestic Sci       Date:  2018-08-20       Impact factor: 1.519

Review 7.  Biomarkers in diabetic retinopathy and the therapeutic implications.

Authors:  Katarzyna Zorena; Dorota Raczyńska; Krystyna Raczyńska
Journal:  Mediators Inflamm       Date:  2013-11-07       Impact factor: 4.711

8.  Evaluation of Ischemia-Modified Albumin, Malondialdehyde, and Advanced Oxidative Protein Products as Markers of Vascular Injury in Diabetic Nephropathy.

Authors:  Afzal Ahmad; Poornima Manjrekar; Charu Yadav; Ashish Agarwal; Rukmini Mysore Srikantiah; Anupama Hegde
Journal:  Biomark Insights       Date:  2016-05-02

Review 9.  How Can Diet Affect the Accumulation of Advanced Glycation End-Products in the Human Body?

Authors:  Axel Guilbaud; Celine Niquet-Leridon; Eric Boulanger; Frederic J Tessier
Journal:  Foods       Date:  2016-12-06

10.  Examination of the Effectiveness of the Healthy Empowered Active Lifestyles (HEAL) Program on Advanced Glycation End Products.

Authors:  Mathew J Gregoski; Janis Newton; Kathleen Blaylock; Sheila A O Smith; David P Turner
Journal:  Int J Environ Res Public Health       Date:  2021-05-02       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.